FDA Advisory Panel Rejects New Cox-2 Painkiller
A panel of advisors to the FDA voted 20 to 1 last week to reject Merck's application to sell its pain medication Arcoxia amid concerns that the drug could cause up to 30,000 heart attacks per year if the drug became widely used.http://www.burgsimpson.com/defective_drugs.html
Continue reading "FDA Advisory Panel Rejects New Cox-2 Painkiller" »













